The inclusion of p19Arf in our gene transfer approach is intended to bring about cell death, an outcome that would resolve the issues related to prolonged exposure to IFNβ and which would provide both antigens and signaling that should contribute to an anti-tumor immune response. Here, IFNB1 is linked to neoplasm.